THOMAS A BUCHHOLZ to Drug Resistance, Neoplasm
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Drug Resistance, Neoplasm.
Connection Strength
0.149
-
Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1225-33.
Score: 0.081
-
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Aug 01; 59(5):1337-42.
Score: 0.023
-
Nuclear factor-kappa B as a predictor of treatment response in breast cancer. Curr Opin Oncol. 2003 Nov; 15(6):405-11.
Score: 0.022
-
Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/?-catenin signaling. Stem Cells. 2012 Nov; 30(11):2366-77.
Score: 0.010
-
Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal. 2005 Nov-Dec; 7(11-12):1630-47.
Score: 0.006
-
Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A. 2005 Jun 07; 102(23):8315-20.
Score: 0.006